|
GNG5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.85564999999333E-05 |
| Normal-vs-Stage3 |
9.28146448586631E-14 |
| Normal-vs-Stage4 |
6.1212146462708E-12 |
| Stage1-vs-Stage2 |
4.478800E-01 |
| Stage1-vs-Stage3 |
6.019600E-01 |
| Stage1-vs-Stage4 |
3.104200E-01 |
| Stage2-vs-Stage3 |
6.656600E-01 |
| Stage2-vs-Stage4 |
2.018200E-01 |
| Stage3-vs-Stage4 |
2.253400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.07689998322058E-09 |
| Normal-vs-Asian |
1.72006853205176E-12 |
| Caucasian-vs-AfricanAmerican |
9.116500E-02 |
| Caucasian-vs-Asian |
1.929010E-01 |
| AfricanAmerican-vs-Asian |
4.878400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.781200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
7.30220328648556E-11 |
| Normal-vs-Age(81-100Yrs) |
1.577170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.083200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.131800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.614100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.252600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.270400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.819000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.175600E-01 |
| Classical-VS-Follicular |
2.269000E-01 |
| Classical-VS-Other |
6.581800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.312820E-01 |
| Tall-VS-Other |
8.756800E-01 |
| Tall-VS-Normal |
9.0176000000497E-09 |
| Follicular-VS-Other |
5.039200E-01 |
| Follicular-VS-Normal |
4.39180000144646E-08 |
| Other-VS-Normal |
1.952080E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62758695410048E-12 |
| Normal-vs-N1 |
7.69517782828189E-12 |
| N0-vs-N1 |
3.588400E-01 |
|
|
